GlassScriptPhysician profile
Ted H Jefferson
NPI 1235152943
$1,275.25
in general payments reported to CMS, 2019-2025
14 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.07 · 2020: $630 · 2022: $95.69 · 2023: $138 · 2024: $231 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $724.67 | 2019-2024 | Juggerknotless Soft Anchor, Dvr Anatomic Kickstand |
| Depuy Synthes Sales INC. | $106.72 | 2024-2025 | Na |
| Organogenesis INC. | $99.63 | 2022-2023 | Puraply |
| Ossio INC | $81.84 | 2023 | |
| Si-Bone, INC. | $46.88 | 2024 | |
| Bioventus LLC | $38.14 | 2020-2022 | |
| Gentleman Orthopedic Solutions | $36.05 | 2025 | |
| Conmed Corporation | $27.66 | 2022 | |
| Curonix LLC | $22.70 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Smith+Nephew, INC. | $22.45 | 2025 | Coblation, Firstpass, Endobutton |
| Linvatec Corporation | $21.40 | 2020 | |
| Solventum Corporation | $16.60 | 2025 | Activ.A.C., Prevena |
| Horizon Therapeutics Plc | $16.28 | 2019 | |
| Boston Scientific Corporation | $14.23 | 2025 | General - Pain Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Jefferson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.